...
首页> 外文期刊>Journal of the Chemical Society, Dalton Transactions. Inorganic Chemistry >Novel ruthenium(III) dimers Na_2[{trans-RuCl_4(Me_2SO-S)}_2(μ-L)] and [{mer, cis-RuCl_3(Me_2SO-S)(Me_2SO_O)}_2(μ-L)](L=bridging heterocyclic N-donor ligand) closely related to the antimetastatic complex Na[trans-RuCl_4(Me_2SO-S)(Him)]
【24h】

Novel ruthenium(III) dimers Na_2[{trans-RuCl_4(Me_2SO-S)}_2(μ-L)] and [{mer, cis-RuCl_3(Me_2SO-S)(Me_2SO_O)}_2(μ-L)](L=bridging heterocyclic N-donor ligand) closely related to the antimetastatic complex Na[trans-RuCl_4(Me_2SO-S)(Him)]

机译:新型钌(III)二聚体Na_2 [{trans-RuCl_4(Me_2SO-S)} _ 2(μ-L)]和[{mer,cis-RuCl_3(Me_2SO-S)(Me_2SO_O)} _ 2(μ-L)]( L =桥接的杂环N-供体配体)与抗转移复合物Na [trans-RuCl_4(Me_2SO-S)(Him)]密切相关

获取原文
获取原文并翻译 | 示例

摘要

The symmetrical dianionic and neutral ruthenium(III) dimers Na_2[{trans-RuCl_4(Me_2SO-S)}_2(μ-L)] 1 and [{mer, cis-RuCl_3(Me_2SO-S)(Me_2SO-O)}_2(μ-L)] 3 (L=pyrazine 1a, 3a; pyrimidine 1b; 4,4′-bipyridine 1c; 1,2-bis(4-pyridyl)-ethane 1d; or 1,3-bis(4-pyridyl)propane 1e), which represent unprecedented examples in the general Creutz-Taube family of ruthenium dimers, were developed with the specific aim of assessing their antineoplastic properties. Each ruthenium center in 1 and 3 has a co-ordination environment similar to that of known anionic and neutral monomeric ruthenium(III) complexes endowed with a specific antimetastatic activity against animal model tumors. Beside the synthesis and spectroscopic characterization of the new dimers, and the structural characterization of 1a, 1b, 1c, and 3a, a through investigation of their chemical behavior in aqueous solution was made. At 25degC and pH 7.4 the dianionic species 1a-1e maintain their dimeric structure and undergo rather slow stepwise chloride hydrolysis to yield the relatively inert diaqua species [{mer, cis-RuCl_3(Me_2SO-S)(H_2O)}_2(μ-L)]. At physiological pH dimers 1a-1e are also easily and quantitatively reduced by equivalent amounts of ascorbic acid to the corresponding Ru~(II/II) dimers which, in turn, undergo stepwise aquation with rates roughly comparable to those of the Ru~(III/III) species of equal net charge. Since the reduction processes might occur also in vivo, the chemical behavior of the Ru~(II/II) dimers is relevant to understanding the biological mechanism of action of these compounds and was thus investigated in detail. The neutral dimer 3, which is scarcely soluble in aqueous solution, gives soluble dimeric species upon reduction with ascorbic acid. We found that reduction is accompanied by O to S linkage isomerization and by partial dissociation of the equatorial dmso. Overall, the dimeric structures of the new compounds are quite robust, both in the Ru~(III/III) and in the Ru~(II/II) form, and they undergo aquation reactions similar to those of the monomeric analogs. However, while the monomeric species after aquation are either mono-or bi-functional binders, the new dimers might behave as bi- or even tetra-functional binders. Thus, it is likely that their interaction with biological targets might lead to adducts which are not accessible to the mononuclear species.
机译:对称的双阴离子和中性钌(III)二聚体Na_2 [{trans-RuCl_4(Me_2SO-S)} _ 2(μ-L)] 1和[{mer,cis-RuCl_3(Me_2SO-S)(Me_2SO-O)} _ 2 (μ-L)] 3(L =吡嗪1a,3a;嘧啶1b; 4,4'-联吡啶1c; 1,2-双(4-吡啶基)-乙烷1d;或1,3-双(4-吡啶基)丙烷1e)代表了一般的Creutz-Taube钌二聚体家族中前所未有的例子,其开发目的是评估其抗肿瘤特性。 1和3中的每个钌中心的配位环境类似于已知的阴离子和中性单体钌(III)配合物,并具有针对动物模型肿瘤的特定抗转移活性。除了合成和新的二聚体的光谱表征,以及1a,1b,1c和3a的结构表征之外,还通过研究它们在水溶液中的化学行为进行了研究。在25°C和pH 7.4下,双阴离子物质1a-1e保持其二聚体结构,并经历相当缓慢的逐步氯化物水解,以产生相对惰性的diaqua物质[{mer,cis-RuCl_3(Me_2SO-S)(H_2O)} _ 2(μ-L )]。在生理pH值下,二聚体1a-1e也可以容易地和定量地被抗坏血酸还原成相应的Ru〜(II / II)二聚体,然后依次进行分步水合,其速率与Ru〜(III)大致相当。 / III)净电荷相等的物种。由于还原过程也可能在体内发生,因此Ru〜(II / II)二聚体的化学行为与理解这些化合物的生物学作用机制有关,因此进行了详细研究。几乎不溶于水溶液的中性二聚体3经抗坏血酸还原后得到可溶的二聚体。我们发现还原伴随着O到S键的异构化和赤道dmso的部分解离。总体而言,新化合物的二聚体结构在Ru〜(III / III)和Ru〜(II / II)形式下都非常坚固,并且它们的水合反应类似于单体类似物。然而,尽管水合后的单体种类是单官能或双官能粘合剂,但是新的二聚体可能表现为双官能或什至四官能粘合剂。因此,它们与生物靶标的相互作用可能导致单核物种无法获得的加合物。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号